Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-866,087 for weight loss in obese adults
NCT00479492Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2007
- Primary completion
- Jan 2008
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CP-866087 in obesity (4 arms), sponsored by Pfizer. Primary endpoints: Body weight at Day 94 and Waist circumference at Day 94. Started Jun 2007; status: completed.
02
Drugs
CP-866087
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00479492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479492.